PMC:7601109 / 5061-5242 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7480","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T18967","span":{"begin":51,"end":57},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"A large number of pharmacological agents are being tested as anti-sarcopenic agents such as bimagrumab (BYM338), enobasarm (GTx-024), trevogrumab (REGN1033), and sarconeos (BIO101)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T31","span":{"begin":0,"end":181},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A large number of pharmacological agents are being tested as anti-sarcopenic agents such as bimagrumab (BYM338), enobasarm (GTx-024), trevogrumab (REGN1033), and sarconeos (BIO101)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"112","span":{"begin":92,"end":102},"obj":"Chemical"},{"id":"113","span":{"begin":104,"end":110},"obj":"Chemical"},{"id":"114","span":{"begin":113,"end":122},"obj":"Chemical"},{"id":"115","span":{"begin":124,"end":131},"obj":"Chemical"},{"id":"116","span":{"begin":134,"end":145},"obj":"Chemical"},{"id":"117","span":{"begin":147,"end":155},"obj":"Chemical"}],"attributes":[{"id":"A112","pred":"tao:has_database_id","subj":"112","obj":"MESH:C000596367"},{"id":"A113","pred":"tao:has_database_id","subj":"113","obj":"MESH:C000596367"},{"id":"A115","pred":"tao:has_database_id","subj":"115","obj":"MESH:C547106"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A large number of pharmacological agents are being tested as anti-sarcopenic agents such as bimagrumab (BYM338), enobasarm (GTx-024), trevogrumab (REGN1033), and sarconeos (BIO101)."}